As of October 31, 2019, the largest concentration of Candida auris cases — 427 of 911 confirmed cases — is in New York4, according to an article on the Infection Control Today website.
“Approximately 3 years into the New York outbreak, these pan-resistant isolates still appear to be rare, but their emergence is concerning,” investigators have said.
C. auris cases in New York are primarily concentrated among hospital patients and nursing home residents in New York City.
The investigators recommended that patients on antifungal treatment for C. auris should be monitored closely for clinical improvement, and follow-up cultures should be obtained.
Study Outlines Hand Hygiene Guidelines for EVS Staff
McCarthy Completes $65M Sharp Rees-Stealy Kearny Mesa MOB Modernization
Florida Cancer Specialists & Research Institute Opens St. Petersburg Bayfront Location
Healthcare Workers Need Better Workplaces
Protecting Patients Through Design and Compliance at Altru Health System